Palatin Technologies Inc (PTN)

0.30 +0.01 (+5.15%) USD  |  NYAM  |  Aug 12, 16:00
0.30 0.00 (0.00%) After-Hours: 20:00
More

Palatin Technologies News

News

Headline
Wire
Time (ET)
Palatin Announces Preliminary Fourth Quarter Vyleesi® Net Product Revenue Increased 225% Over Prior Quarter
PR Newswire
07/26 07:30
Aldeyra's (ALDX) Dry Eye Disease Chamber Study Meets Goals
Yahoo
07/13 10:53
Palatin Technologies, Inc. (PTN) Reports Q3 Loss, Misses Revenue Estimates
Yahoo
05/17 08:45
-- Earnings Flash (PTN) PALATIN TECHNOLOGIES Posts Q3 Revenue $216,097
MT Newswires
05/17 07:39
Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
PR Newswire
05/17 07:30
Notable earnings before Tuesday's open
SA Breaking News
05/16 12:23
PhaseBio Pharmaceuticals (PHAS) Reports Q1 Loss, Misses Revenue Estimates
Yahoo
05/16 07:15
Palatin Announces $15 Million Private Placement of Convertible Redeemable Preferred Stock
PR Newswire
05/12 08:00
Palatin to Report Third Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on May 17, 2022
PR Newswire
05/11 09:02
Palatin to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Conference
PR Newswire
05/02 13:02
Palatin Hosting Key Opinion Leader Webinar on Dry Eye Disease
PR Newswire
03/03 07:30
Palatin Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
PR Newswire
02/15 07:30
Palatin to Report Second Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on February 15, 2022
PR Newswire
02/10 07:30
Palatin Announces Presentation at the 2022 Crohn's and Colitis Congress
PR Newswire
01/21 07:30
Palatin Technologies Starts Late-Stage Dry Eye Disease Trial
MT Newswires
12/28 07:52
Palatin Announces Initiation of Pivotal Phase 3 PL9643 MELODY-1 Clinical Trial in Patients with Dry Eye Disease
PR Newswire
12/28 07:30
Thinking about buying stock in American Airlines, Palatin Technologies, Blue Owl Capital, Seanergy Maritime, or Li Auto?
PR Newswire
12/07 10:31
Thinking about buying stock in NLS Pharmaceutics, Petros Pharmaceuticals, Palatin Technologies, TG Therapeutics, or Qualigen Therapeutics?
PR Newswire
11/30 11:33
Palatin Gets US Patent to Use Melanocortin Peptides to Treat Immune System Dysregulation
MT Newswires
11/30 11:05
Notice of Allowance Issued for Method of Treating Cytokine Storm Using Melanocortin-Specific Peptide
PR Newswire
11/30 07:30
Thinking about buying stock in Petros Pharmaceuticals, Palatin Technologies, cbdMD, RLX Technology, or Merck?
PR Newswire
11/29 10:45
Top Premarket Gainers
MT Newswires
11/29 08:21
PTN, OCUP and FEMY among technology movers
SA Breaking News
11/24 15:00
Thinking about buying stock in Palatin Technologies, ContextLogic, Nordstrom, Aptevo Therapeutics, or BioNano Genomics?
PR Newswire
11/24 10:55
--HC Wainwright Adjusts Palatin Technologies' Price Target to $5 From $2, Keeps Buy Rating
MT Newswires
11/24 07:18
-- Earnings Flash (PTN) PALATIN TECHNOLOGIES Reports Q1 Revenue $159,482, vs. Street Est of $0.073M
MT Newswires
11/15 07:31
Palatin Reports First Quarter Fiscal Year 2022 Results and Provides Corporate Update
PR Newswire
11/15 07:30
Palatin Awarded "Top 10 Poster" Designation at the American Society of Retina Specialists (ASRS) 2021 Annual Meeting
PR Newswire
10/22 07:30
Notable earnings before Wednesday's open
SA Breaking News
09/28 11:00
Palatin Announces Presentation of Positive Protective Effects of PL8331 and PL9654 on Retinal Inflammation at the 2021 American Society of Retina Specialists (ASRS) Annual Meeting
PR Newswire
09/27 07:30
Palatin To Report Fourth Quarter And Fiscal Year End 2021 Results; Teleconference And Webcast To Be Held On September 29, 2021
PR Newswire
09/24 07:30
Palatin to Present Peptides Platform at the TIDES USA Conference
PR Newswire
09/15 07:30
Palatin Announces Presentation at the Eyecelerator@ASCRS Conference
PR Newswire
07/22 17:28
Palatin Announces Adjournment of Annual Meeting of Stockholders
PR Newswire
07/08 16:15
Thinking about buying stock in ContextLogic, Orphazyme, Marin Software, Xpeng, or Palatin Technologies?
PR Newswire
06/29 10:45
Palatin shares rise after completing PL9643 End-of-Phase 2 meeting with FDA
SA Breaking News
06/29 07:39
Palatin Announces Positive End-of-Phase 2 Meeting with FDA on PL9643 for the Treatment of Dry Eye Disease
PR Newswire
06/29 07:30
Palatin Announces New Additions to Its Senior Leadership Team
PR Newswire
06/28 07:30
Palatin Announces Adjournment of Annual Meeting of Stockholders
PR Newswire
06/10 07:30
Palatin Tech EPS beats by $0.02, misses on revenue
SA Breaking News
05/17 07:34
-- Earnings Flash (PTN) PALATIN TECHNOLOGIES Posts Q3 Revenue $88,741, vs. Street Est of $0.888M
MT Newswires
05/17 07:32
-- Earnings Flash (PTN) PALATIN TECHNOLOGIES Posts Q3 Loss $-0.02, vs. Street Est of $-0.04
MT Newswires
05/17 07:31
Palatin Reports Financial Results for the Third Fiscal Quarter of 2021 and Provides Corporate Update
PR Newswire
05/17 07:30
Palatin Hosting Key Opinion Leader Webinar in Role of Melanocortin Agonists in Inflammation and the Treatment of Ocular Indications
PR Newswire
05/14 07:30
Palatin to Report Third Quarter, Fiscal Year 2021 Results; Teleconference and Webcast to be held on May 17, 2021
PR Newswire
05/13 07:30
Palatin Announces U.S. Patent Term Extension for Vyleesi® (bremelanotide injection)
PR Newswire
05/04 07:30
Palatin Announces Two Presentations at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
PR Newswire
04/20 07:30
Palatin Technologies to Participate in H.C. Wainwright Global Life Sciences Virtual Conference
PR Newswire
03/05 07:30
EH, PTN, ONTX and SHIP among midday movers
SA Breaking News
02/17 12:40
SNDL, IMUX among premarket losers
SA Breaking News
02/17 08:39
Palatin Technologies shares slide after wider quarterly net loss
SA Breaking News
02/17 08:04
Palatin Tech EPS misses by $0.02
SA Breaking News
02/17 07:31
Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2021 Financial Results and Recent Business Highlights
PR Newswire
02/17 07:30
Palatin Technologies, Inc. to Report Second Quarter, Fiscal Year 2021 Results; Teleconference and Webcast to be held on February 17, 2021
PR Newswire
02/12 07:30
Palatin Technologies Seeks US, International Patent Coverage for PL9643 for Treatment of Dry Eye Disease
MT Newswires
02/10 10:01
Palatin Technologies Announces Filing of International Patent Application Claiming PL9643
PR Newswire
02/10 07:30
IBM, GSAT among premarket losers
SA Breaking News
01/22 08:29
Thinking about buying stock in Palatin Technologies, Motus GI Holdings, Tellurian, OncoCyte, or Endra Life Sciences?
PR Newswire
01/21 09:31
Palatin's PL9643 ophthalmic solution misses primary endpoint in mid-stage dry eye disease study
SA Breaking News
12/15 08:11
Palatin Technologies Announces Positive Results From its Phase 2 Study of PL9643 in Patients With Dry Eye Disease
PR Newswire
12/15 07:00
Palatin Technologies down 3% on Q3 earnings miss
SA Breaking News
11/17 10:45
Palatin Tech EPS misses by $0.01
SA Breaking News
11/17 07:36
Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2021 Results and Provides Business Update
PR Newswire
11/17 07:30
Palatin Technologies, Inc. to Report First Quarter, Fiscal Year 2021 Results; Teleconference and Webcast to be held on November 17, 2020
PR Newswire
11/12 07:30
Palatin Technologies FQ4 results highlight $12M receipt from AMAG
SA Breaking News
09/28 14:21
Palatin Tech EPS misses by $0.01
SA Breaking News
09/28 07:35
Palatin Technologies, Inc. Announces Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Business Update
PR Newswire
09/28 07:30
Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2020 Results; Teleconference and Webcast to be held on September 28, 2020
PR Newswire
09/24 16:00
Palatin Technologies To Present At The H.C. Wainwright & Co. 22nd Annual Global Investment Conference
PR Newswire
09/10 17:47
Peloton prints new high as company looks to be global wellness leader
SA Breaking News
09/01 10:20
Palatin Technologies Participates In Canaccord Genuity's 40th Annual Growth Conference
PR Newswire
08/13 16:12
Palatin Technologies, Inc. Announces Completion of Enrollment of Phase 2 Study with PL9643 for the Treatment of Dry Eye Disease
PR Newswire
08/05 07:30
AMAG Pharma to Pay $16.3 Million to Terminate License Deal, Return Sexual Disorder Drug Vyleesi to Palatin; AMAG Down 5%, PTN Up 8%
MT Newswires
07/27 11:13
Palatin Tech puts end to Vyleesi license agreement with Amag Pharma
SA Breaking News
07/27 08:39
Palatin Tech and Amag Pharma ax Vyleesi agreement
SA Breaking News
07/27 08:39
Palatin Technologies Announces Mutual Termination of License Agreement with AMAG Pharmaceuticals for Vyleesi®
PR Newswire
07/27 07:00
Palatin Technologies Restarts Enrollment in Phase 2 Study of Dry Eye Disease Treatment
MT Newswires
07/08 12:46
Palatin resumes enrollment in mid-stage dry eye study
SA Breaking News
07/08 09:20
Palatin Technologies, Inc. Announces Reinitiation of Enrollment of Phase 2 Study with PL9643 for the Treatment of Dry Eye Disease
PR Newswire
07/08 07:30
Palatin Technologies Announces Adjournment of Annual Meeting of Stockholders
PR Newswire
06/29 07:30
Palatin Technologies to Develop PL8177 as Potential Treatment for COVID-19, Lung Complications; Shares Rise 25%
MT Newswires
06/23 11:53
Wall Street Sees Upbeat Session Following Trump's Trade Comments
MT Newswires
06/23 09:06
US Futures Rise on Trump Trade Comments
MT Newswires
06/23 08:26
Palatin Technologies to Develop PL8177 as a Potential Treatment for COVID-19 and Associated Lung Complications
PR Newswire
06/23 07:30
Palatin Tech EPS in-line
SA Breaking News
05/12 07:33
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2020 Financial Results and Recent Business Highlights
PR Newswire
05/12 07:30
Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2020 Results; Teleconference and Webcast to be held on May 12, 2020
PR Newswire
05/07 07:30
Palatin Technologies Provides Assessment of Impact of COVID-19 Pandemic on Business Operations
PR Newswire
04/30 07:30
Palatin Technologies Enrols First Patient in Phase Two Study of Topical Eye Drops for Treatment of Dry Eye Disease
MT Newswires
02/19 13:31
Mid-stage study underway evaluating Palatin's PL9643
SA Breaking News
02/19 12:08
Palatin Technologies, Inc. Announces First Patient Enrolled in Dry Eye Disease Phase 2 Clinical Trial with PL9643
PR Newswire
02/19 07:30
Wells cuts view on Teladoc in premarket analyst action
SA Breaking News
02/12 08:08
Palatin Tech slips 14% premarket on Q2 miss
SA Breaking News
02/11 07:48
Palatin Tech EPS misses by $0.01, misses on revenue
SA Breaking News
02/11 07:32
Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2020 Financial Results and Recent Business Highlights
PR Newswire
02/11 07:30
Palatin Technologies Plans Two Mid-Stage Trials in 2020
MT Newswires
01/21 12:30
Palatin provides 2020 outlook
SA Breaking News
01/21 09:02
Palatin Provides Corporate Update and 2020 Calendar Outlook
PR Newswire
01/21 07:30
Oyster Point Pharma up 5% on positive data on lead candidate
SA Breaking News
01/13 14:11
Palatin Technologies Fiscal Q1 Loss In-Line With Consensus, Revenue Misses Estimates; Shares Drop 3% Pre-Bell
MT Newswires
11/13 08:05
Palatin Tech down 2% premarket on Q1 report
SA Breaking News
11/13 07:46
Palatin Tech EPS in-line, misses on revenue
SA Breaking News
11/13 07:32
Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2020 Results and Provides Corporate Update
PR Newswire
11/13 07:30
Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2020 Results; Teleconference and Webcast to be held on November 13, 2019
PR Newswire
11/07 07:30
Palatin Presents On Pl8177 Oral Colon Delivery Formulation For Ulcerative Colitis At The 7Th CPC Symposium On Peptide Therapeutics
PR Newswire
10/17 07:00
Vyleesi™ Phase 3 Data To Be Presented At The 13th European Society Of Gynecology Congress
PR Newswire
10/16 07:00
Stocks End Slightly Down as Chinese Official's Trade Remarks Bring Market Off Session Lows
MT Newswires
09/26 16:41
Thinking about buying stock in Canopy Growth, Micron Technology, Palatin Technologies, SINTX Technologies, or Tilray?
PR Newswire
09/12 09:31
Palatin Technologies Fiscal Q4 EPS, Revenue Increase; Shares Up 6% Pre-Market
MT Newswires
09/12 08:11
Palatin Tech up 7% premarket on FY 2019 results
SA Breaking News
09/12 07:52
Palatin Tech EPS beats by $0.26
SA Breaking News
09/12 07:33
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2019 Results
PR Newswire
09/12 07:30
Palatin Technologies, Inc. to Report Fourth Quarter & Fiscal Year End 2019 Results; Teleconference and Webcast to be held on September 12, 2019
PR Newswire
09/11 12:00
Palatin Technologies To Present At Canaccord Genuity's 39th Annual Growth Conference
PR Newswire
08/06 07:00
Palatin Technologies Offers Mid-Year Update; Shares Advance 2%
MT Newswires
07/01 09:41
Palatin Tech provides corporate update; shares up 5% premarket
SA Breaking News
07/01 07:42
Palatin Technologies Provides Mid-Calendar Year Corporate Update
PR Newswire
07/01 07:00
ABBV and ACER among premarket losers
SA Breaking News
06/25 09:17
Sector Update: Health Care Stocks Unable to Find Traction This Afternoon
MT Newswires
06/24 15:59
Sector Update: Health Care Stocks Drifting Lower
MT Newswires
06/24 13:54
Palatin and AMAG give up gains after Feuerstein rains on Vyleesi parade
SA Breaking News
06/24 12:31
Thinking about buying stock in Aurora Cannabis, AMAG Pharmaceuticals, Minerva Neurosciences, Palatin Technologies, or Zoom Video Communications?
PR Newswire
06/24 09:31
Sector Update: Health Care Majors Mixed In Monday's Pre-Market Trading
MT Newswires
06/24 09:26
RIOT, CZR among premarket gainers
SA Breaking News
06/24 09:15
Wall Street Sees Cautiously Higher Open Amid Growing Iran-US Tensions, Expectations of China-US Meeting
MT Newswires
06/24 09:04
Sector Update: Health Care
MT Newswires
06/24 08:42
US Futures Slightly Higher Amid Growing Iran-US Tensions
MT Newswires
06/24 08:07
Palatin earns $60M milestone on Vyleesi approval in U.S.; shares up 49% premarket
SA Breaking News
06/24 06:47
Palatin To Receive $60 Mln Mlestone Payment from AMAG Pharmaeuticals for FDA OK of Vyleesi
MT Newswires
06/23 23:07
Key events this week - healthcare
SA Breaking News
06/23 20:09
LKSD, PTN, AMAG and MBIO among notable after hour movers
SA Breaking News
06/21 17:58
FDA Approves New Drug Application for Vyleesi™ (bremelanotide injection)
PR Newswire
06/21 17:40
Amag +11.5%, Palatin +42.6% on FDA's Vyleesi approval
SA Breaking News
06/21 17:25
Amag up, Palatin down with decision on 'female Viagra' looming
SA Breaking News
06/21 12:21
CGC and BYND among premarket losers
SA Breaking News
06/21 09:13
Palatin Technologies' Uveitis Drug Granted Orphan Drug Designation by FDA -- Shares Up More Than 4%
MT Newswires
06/06 07:50
Palatin Technologies Granted FDA Orphan Drug Designation -- PL-8177 for the Treatment of Non-Infectious Uveitis
PR Newswire
06/06 07:30
AMBA, AEO among premarket gainers
SA Breaking News
06/05 09:15
MNKD, CLDX among premarket gainers
SA Breaking News
06/03 09:23
S, TMUS among premarket gainers
SA Breaking News
05/20 09:15
GEVO, TRQ among premarket gainers
SA Breaking News
05/16 09:21
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on May 9, 2019
PR Newswire
05/09 07:30
Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on May 9, 2019
PR Newswire
05/03 16:30
Palatin Technologies Discloses 'Positive' Results From Study of Ulcerative Colitis, Other Inflammatory Bowel Diseases - Shares Advance
MT Newswires
04/04 13:59
Wall Street Sees Narrowly Mixed Open as Trade Talks Continue
MT Newswires
04/04 09:10
Palatin up 16% premarket on positive PL-8177 data
SA Breaking News
04/04 07:52
Palatin Technologies Announces Positive Top Line Results of Oral Clinical Study of PL-8177 for Ulcerative Colitis and Other Inflammatory Bowel Diseases
PR Newswire
04/04 07:30
Key events next week - healthcare
SA Breaking News
03/15 08:53
Analysis: Positioning to Benefit within Weatherford International, NiSource, Palatin Technologies, Astronics, MaxLinear, and FutureFuel — Research Highlights Growth, Revenue, and Consolidated Results
Globe Newswire
02/26 07:40
Palatin Tech down 8% on Q2 results
SA Breaking News
02/12 07:47
Palatin Tech beats by $0.01
SA Breaking News
02/12 07:32
Palatin Technologies, Inc. Reports Second Fiscal Quarter 2019 Results and Provides Corporate Update
PR Newswire
02/12 07:30
Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on February 12, 2019
PR Newswire
02/06 07:30
MTNewswires After-Hours News Movers
MT Newswires
02/05 17:54
Palatin Technologies Files $100 Mln Mixed Shelf
MT Newswires
02/05 17:03
Palatin Tech files for $100M mixed shelf offering
SA Breaking News
02/05 16:59
FDA action date for Palatin's Vyleesi extended to June 23
SA Breaking News
01/07 16:29
Market Trends Toward New Normal in Palatin Technologies, Revance Therapeutics, Geo Group, QUANTENNA COMMS, The Navigators Group, and INVESCO MORTGAGE CAPITAL INC — Emerging Consolidated Expectations, Analyst Ratings
Globe Newswire
11/27 07:40
Palatin Technologies CEO and CFO Buy Company Shares - Stock Up 9% After-Hours
MT Newswires
11/19 17:58
Palatin Tech +8.8% as CEO, COO/CFO disclose share purchases
SA Breaking News
11/19 17:45
Palatin Techn down 3% on Q1 results
SA Breaking News
11/13 07:49
Palatin Tech beats by $0.01, misses on revenue
SA Breaking News
11/13 07:32
Palatin Technologies, Inc. Reports First Fiscal Quarter 2019 Results and Provides Corporate Update
PR Newswire
11/13 07:30
Palatin Technologies, Inc. Announces First-in-Human Study Results of Subcutaneous Administration of PL-8177, An Investigational Melanocortin Receptor 1 Agonist
PR Newswire
11/08 07:30
Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on November 13, 2018
PR Newswire
11/07 16:15
Recent Analysis Shows Booz Allen Hamilton Holding, j2 Global, Leidos, The Hain Celestial Group, Palatin Technologies, and Marsh & McLennan Companies Market Influences — Renewed Outlook, Key Drivers of Growth
Globe Newswire
10/12 07:55
Immunotherapy Market Value Grows as the Treatments Gains Widespread Importance
PR Newswire
09/13 09:00
Palatin Technologies Fiscal Q4 Results Exceed Expectations - Shares Up 1% Pre-Bell
MT Newswires
09/13 08:58
Palatin Tech beats by $0.06, beats on revenue
SA Breaking News
09/13 07:37
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2018 Results
PR Newswire
09/13 07:30
Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2018 Results; Teleconference and Webcast to be held on September 13, 2018
PR Newswire
09/07 16:00
Global Biotechnology Market Grows as Demand for Immunotherapy Cancer Treatment Increases
PR Newswire
09/07 09:00
Abivax UC candidate shows positive action in mid-stage study
SA Breaking News
09/05 12:17
Palatin Tech files for $100M mixed shelf offering
SA Breaking News
08/17 16:31
Palatin Technologies Files for $100 Mln Mixed Shelf - Stock Down 2% After-Hours
MT Newswires
08/17 16:18
Analysis: Positioning to Benefit within FIS, Helix Energy, Palatin Technologies, NiSource, Service Corporation International, and Summit Hotel Properties — Research Highlights Growth, Revenue, and Consolidated Results
Globe Newswire
08/10 07:30
Palatin Technologies Added to Russell 3000 Index
MT Newswires
06/25 17:02
Palatin Technologies Added to Russell 3000® Index
PR Newswire
06/25 16:56
Sector Update: Late Bump Boosts Health Care Sector
MT Newswires
06/04 16:04
Sector Update: Health Care Stocks Edging Higher in Recent Trading
MT Newswires
06/04 13:36
Premarket Gainers as of 9:05 am (06/04/2018)
SA Breaking News
06/04 09:17
Sector Update: Health Care Stocks Higher in Pre-Market; Palatin Higher on FDA Acceptance for Bremelanotide NDA for Review
MT Newswires
06/04 08:47
Sector Update: Health Care
MT Newswires
06/04 08:02
FDA accepts Palatin Technologies' NDA review for bremelanotide
SA Breaking News
06/04 07:47
AMAG Application for Women's Sexuality Drug Accepted by FDA, Palatin to Receive $20 Mln Milestone
MT Newswires
06/04 07:43
Palatin Says FDA Accepts Bremelanotide NDA for Review, Earns $20 Mln Milestone Payment from Amag Pharma
MT Newswires
06/04 07:39
Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA
PR Newswire
06/04 07:10
Close Update: Wall Street Snaps Winning Streak With Dow Skidding as U.S. Yields Spike
MT Newswires
05/15 16:21
Midday Update: Dow Capitulates to Trade Tensions
MT Newswires
05/15 12:49
Palatin Tech revenues down 17%; net loss improves in Q1
SA Breaking News
05/15 09:30
Palatin Technologies Fiscal Q3 EPS Beats Views - Shares Up 2% Pre-Bell
MT Newswires
05/15 08:23
Palatin Tech beats by $0.04
SA Breaking News
05/15 07:32
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018
PR Newswire
05/15 07:30
Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018
PR Newswire
05/10 16:30
Factors of Influence in 2018, Key Indicators and Opportunity within American Homes 4 Rent, Discovery Communications, Vertex Pharmaceuticals, The New York Times, Palatin Technologies, and E*TRADE Financial — New Research Emphasizes Economic Growth
Globe Newswire
05/10 08:10
Premarket Gainers as of 9:05 am (05/09/2018)
SA Breaking News
05/09 09:20
Palatin Technologies Presents Positive Preclinical MC1 Receptor Agonist Data at TIDES: Oligonucleotide and Peptide Therapeutics 2018 Meeting in Boston, Massachusetts
PR Newswire
05/09 07:30
Palatin Technologies Declines After Company Discloses Intention to Sell $25 Mln of Shares
MT Newswires
04/23 14:02
Premarket Losers as of 9:05 am (4/23/2018)
SA Breaking News
04/23 09:19
Premarket Losers as of 9:05 am (04/19/2018)
SA Breaking News
04/19 09:24
Premarket Gainers as of 9:05 am (04/10/2018)
SA Breaking News
04/10 09:25
Analyst Actions: HC Wainwright Initiates Coverage on Palatin Technologies With Buy Rating and $5 PT
MT Newswires
04/06 07:25
Premarket analyst action - healthcare
SA Breaking News
04/06 07:22
Palatin Technologies Presents Preclinical Oral Formulation Data on PL-8177, An Investigational Melanocortin Receptor 1 Agonist for Inflammatory Bowel Diseases
PR Newswire
04/03 07:30
Palatin, Amag File NDA in US for Bremelanotide for Treatment of HSDD in Pre-Menopausal Women
MT Newswires
03/26 10:38
AMAG Pharma files U.S. marketing application for HSDD med bremelanotide
SA Breaking News
03/26 09:57
Premarket Gainers as of 9:05 am (03/26/2018)
SA Breaking News
03/26 09:17
Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
PR Newswire
03/26 08:00
Detailed Research: Economic Perspectives on HMS, Colfax, Fossil Group, Palatin Technologies, FIS, and Commercial Metals — What Drives Growth in Today's Competitive Landscape
Globe Newswire
03/08 07:50
Sector Update: Health Care Stocks Higher in Pre-Market; Axovant Sciences Tanks on Resignation of CEO, COO
MT Newswires
02/12 08:51
Palatin Tech reports Q4 results
SA Breaking News
02/12 07:47
Palatin Tech reports Q2 results
SA Breaking News
02/12 07:31
Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on February 12, 2018
PR Newswire
02/12 07:30
Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on February 12, 2018
PR Newswire
02/07 16:00
Early-stage study underway assessing Palatin's lead candidate PL-8177
SA Breaking News
02/05 11:07
Palatin Starts Patient Dosing in Phase 1 Trial of PL-8177 in Bowel Diseases
MT Newswires
02/05 10:01
Palatin Technologies, Inc. Initiates Subject Dosing in First-in-Human Clinical Study of PL-8177, an Investigational Melanocortin Receptor 1 Agonist
PR Newswire
02/05 07:30
The Biotechnology Market is Projected to Grow
PR Newswire
01/26 09:00
Biotech and Pain Management Therapeutics Segments Projected to Grow
PR Newswire
01/12 09:00
Sector Update: Health Care Stocks Steady in Pre-Market; Egalet Shares Surge Pre-Bell on Valeant Partnership on Sprix Pain Relief Nasal Spray
MT Newswires
01/03 08:41
Palatin to start clinical development of UC candidate PL-8177; shares up 6% premarket
SA Breaking News
01/03 08:01
Palatin Technologies Gets FDA Clearance for Clinical Investigation of Subcutaneous Injection PL-8177 For Ulcerative Colitis
MT Newswires
01/03 07:56
Palatin Technologies, Inc. Announces FDA Clearance of Investigational New Drug (IND) Application for PL-8177 For Ulcerative Colitis
PR Newswire
01/03 07:30
Technical Perspectives on Palatin Technologies, Atossa Genetics, DBV Technologies, and IDEXX Labs
PR Newswire
12/11 06:15
Palatin establishes bremelanotide distribution in Korea; shares ahead 7%
SA Breaking News
11/21 12:44
Palatin Tech Grants Rights to Kwangdong Pharma to Develop Treatment for Female Sexual Dysfunction
MT Newswires
11/21 08:06
Palatin Technologies Announces Signing of Licensing Agreement with Kwangdong Pharmaceutical for Republic of Korea
PR Newswire
11/21 07:30
Recent Analysis Shows Nielsen Holdings, Palatin Technologies, MasTec, Iconix Brand, Eversource Energy, and Booz Allen Hamilton Holding Market Influences – Renewed Outlook, Key Drivers of Growth
Globe Newswire
11/14 08:10
Palatin Tech reports Q1 results
SA Breaking News
11/13 07:34
Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on November 13, 2017
PR Newswire
11/13 07:30
Earnings Reaction History: Palatin Technologies Inc., 33.3% Follow-Through Indicator, 4.5% Sensitive
MT Newswires
11/13 06:27
Palatin Tech reports Q4 results
SA Breaking News
09/25 07:36
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2017 Results; Teleconference and Webcast to be held on September 25, 2017
PR Newswire
09/25 07:30
Earnings Reaction History: Palatin Technologies Inc., 33.3% Follow-Through Indicator, 4.3% Sensitive
MT Newswires
09/25 06:14
Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2017 Results; Teleconference and Webcast to be held on September 25, 2017
PR Newswire
09/20 16:15
Today's Research Report Coverage on Healthcare Stocks -- AMAG Pharma, IDEXX Laboratories, Palatin Technologies, and Bio-Path
PR Newswire
09/20 06:20
Palatin Technologies Announces Appointment of Anthony M. Manning, Ph.D. to Board of Directors
PR Newswire
09/12 07:30
Midday Update: Wall Street Stages Comeback on Bargain Hunting, Technical Support
MT Newswires
09/06 12:57
Palatin Tech inks bremelanotide commercialization deal in China; shares up 8%
SA Breaking News
09/06 11:25
Futures Bounce Back As Wall Street Shops For Bargains
MT Newswires
09/06 09:11
Palatin Technologies Signs Licensing Deal with Fosun Pharma for Rights to Bremelanotide in China
MT Newswires
09/06 08:19
Palatin Technologies Announces Signing of Licensing Agreement with Fosun Pharma Rights to Bremelanotide in China and Other Selected Territories
PR Newswire
09/06 07:30
Recent Developments in the Pharmaceutical Industry
PR Newswire
09/05 09:00
Stock Performance Review on Healthcare Sector -- Palatin Technologies, Centene, Anthem, and AMAG Pharma
PR Newswire
06/08 07:10
FMC Issues 'Built for Progress' Sustainability Report for 2016
PR Newswire
06/06 06:00
Palatin Tech misses by $0.12, misses on revenue
SA Breaking News
05/16 07:33
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on May 16, 2017
PR Newswire
05/16 07:30
Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on May 16, 2017
PR Newswire
05/11 07:30
Research Reports Initiation on Diagnostic Substances Stocks -- Palatin Technologies, AMAG Pharma, IDEXX Labs, and Meridian Bioscience
PR Newswire
04/19 07:00
Midday Update: Dow Pushes Into Positive Territory, Nasdaq Sets Record High
MT Newswires
03/20 12:49